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We report a case of a young woman with acute reversible cerebellar ataxia secondary to 
ovarian teratoma with no identifiable serum antibodies.  
 
1.0 Case report 
 
A 25-year-old Somali woman presented with acute ataxia, dysarthria, dizziness and blurred 
vision on standing, preceded by a week of epigastric pain and recurrent vomiting. The 
gastrointestinal symptoms were initially diagnosed as viral gastroenteritis. One month prior to 
the presentation, she had fever, headache and arthralgia lasting one week. Her past medical 
history included vitamin D deficiency, for which she was on vitamin D supplementation. She 
had a strong family history of autoimmunity. Her mother and maternal grandmother suffered 
from rheumatoid arthritis and one of her maternal aunts suffered from systemic lupus 
erythematosus. She denied taking any other supplements or recreational drug use.  She did not 
consume alcohol, tobacco or marijuana. She migrated from Kenya but had no recent overseas 
travel.  On examination, she had wide based ataxic gait with difficulty sitting unsupported. 
There was head titubation, saccadic overshoot on right gaze, and bilateral rebound of upper 
limbs. Appendicular dysmetria and dysdiadochokinesia were evident on testing. Reflexes 
were brisk but equal throughout. She did not have any weakness or sensory deficits. 
Hoffman’s sign was negative and plantar response was down-going.   
 
Investigations showed mild lymphocytosis in the cerebrospinal fluid (CSF) and positive 
oligoclonal bands. Paraneoplastic antibodies including anti-Hu, Yo, Ri, amphiphysin, 
CRPM5, Ma1/2, Tr, N-methyl-D-aspartate [NMDA] receptor and GAD-65 antibodies were 
negative. Autoimmune screen including ANA, ENA, dsDNA were normal. Further laboratory 
results are detailed in supplemental Table 1. Brain magnetic resonance imaging (MRI) was 
within normal limits. Computed tomography of the chest and abdomen revealed a partially 
fatty and partially calcified ovoid mass in the left adnexa measuring 25mm and peribronchial 
ground glass infiltrate in the left apex of the lung. Pelvic ultrasound confirmed features 
consistent with left ovarian dermoid cyst.  Breast ultrasound did not show any suspicious 
lesions.  
The patient had ongoing nausea, vomiting and worsening ataxia. The gynaecology team did 
not feel that the dermoid cyst was relevant to the patient’s presentation. Gastroscopy and 
bronchoscopy were therefore performed and were normal. Positron emission tomography 
(PET) showed a moderately fludeoxyglucose(FDG)-avid left ovarian lesion. Due to concerns 
of malignant transformation, a left oophorectomy was performed one month into the 
admission. Histopathology demonstrated a mature teratoma with aggregates of reactive 
lymphoid cells around the neural tissue (Figure 1). We treated her with intravenous 
methylprednisolone and intravenous immunoglobulin subsequent to the oophorectomy. The 
patient improved rapidly over two weeks and returned to almost baseline function by six 
months, with no recurrence of symptoms at one-year.  
2.0 Discussion 
Ovarian tumours are associated with paraneoplastic cerebellar degeneration, opsoclonus-
ataxia syndrome(1) and anti-NMDAR encephalitis(2). Teratomas are the most common 
ovarian tumours below the age of 30 but the exact prevalence is unknown(3). Although they 
are often asymptomatic with low potential for malignant transformation, this case illustrates 















in this case potentially reflects an inflammatory process and corresponds with inflammatory 
infiltrates within the teratoma. This lends support to the diagnosis of neurological 
paraneoplastic phenomenon. In a recent case series of 249 patients with teratoma-associated 
encephalitis, 22 antibody-negative patients developed a brainstem-cerebellar syndrome(4). 
Three quarters of them fully recovered after tumour resection and immunotherapy. We 
postulate that there is cross-presentation of an unidentified antigen on both the teratoma and 
cerebellar Purkinje cells, with an unknown precipitant such as a viral infection. Neurologists 
should consider ovarian teratoma as a potential reversible paraneoplastic syndrome in a young 
woman presenting with acute ataxia. 
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Table 1. Laboratory tests 
Hb, haemoglobin; WBC, white cell count; Plt, platelet count; Bili, bilirubin; ALT, alanine aminotransferase; Na, 
sodium; K, potassium; Ca, calcium; BUN, blood urea nitrogen; Crea, creatinine; CRP, C-reactive protein; ESR, 
erythroycyte sedimentation rate; TSH, thyroid stimulating hormone; TPO, thyroid peroxidase antibodies; ANA, 
antinuclear antibodies; ENA, extractable nuclear antigens; ANCA, anti-neutrophil cytoplasmic antibodies; 
dsDNA, double standed deoxyribonucleic acid antibodies; ACE, angiotensin converting enzyme; RhF, 
rheumatoid factor; ttG IgA, tissue transglutaminase antibodies immunoglobulin A; C3/4, complement ¾; vit, 
vitamin, bHCG, beta human chorionic gonadotropin; HIV, human immunodeficiency virus; NMDAR, N-methyl-
D-aspartate receptor; GAD-65, glutamic acid decarboxylase 65 antibodies; PCR, polymerase chain reaction. 
 
  
Blood tests     
Hb 144g/L ANA 2U/nL Hu (ANNA-1) Negative 
WCC 5×10*9/L ENA Negative Yo (PCA1) Negative 
Plt 428×10*9/L ANCA <2units Ri (ANNA-2) Negative 
Bili <2μmol/L dsDNA <1U/mL Amphiphysin Negative 
ALT 9U/L ACE 48U/L CV2 (CRPM5) Negative 
Na 137mmol/L RhF <10kU/L Ma1/2 Negative 
K 3.6mmol/L tTg IgA <1U/mL NMDAR Negative 
Ca 2.37mmol/L C3 1.13g/L Tr (PCA2) Negative 
BUN 2.1mmol/L C4 0.3g/L GAD-65 0.2 
Crea 44μmol/L Vit E 25μmol/L AQP4 0 
CRP <1.0mg/L Folate 39.9nmol/L Ganglioside 
antibodies  
Negative 
ESR 16mm/hr Vit B12 790pmol/L   
TSH 3.8 mU/L bHCG  <1U/L   
TPO <1kU/L HIV 
serology 
Negative   
       
Cerebral spinal fluid 
Gross appearance Colourless 





Oligoclonal bands Positive 
NMDAR Negative 
GAD-65 Negative 
Herpes virus PCR Negative 
Cytology Mild lymphocytosis 
Flow Cytometry No monoclonal B cell or aberrant T cell population 
Crytococcal antigen Negative 



















Figure 1. The upper panel shows an overview of part of the teratoma with hematoxylin 
and eosin stain. There are tissue from all three embryological layers. These include 
















tissue from ectoderm. All tissue is mature. The lower panel showes a high power view 
(magnification by 100) of neural tissue composed of spindle cells in a fibrillary 
background and neuronal cells, adjacent to aggregates of reactive lymphoid cells. 
Courtesy of Dr Ebo Oost PathWest Laboratory Medicine Western Australia, King Edward 
Memorial Hospital. 
